Get a Quote
Please use this form for bulk quantity requests or customized products.
Pharmacokinetic ELISA Kits
Quantify therapeutic drug concentrations in serum, plasma, and tissue with assays optimized for biologic monitoring. Our PK ELISA kits are designed for preclinical and clinical pharmacokinetic studies — covering therapeutic antibodies including Adalimumab (Humira), Natalizumab (Tysabri), Tocilizumab (Actemra), Omalizumab (Xolair), and more. Each kit is validated for sensitivity, specificity, and matrix compatibility to support reliable drug exposure data across study timepoints.
60Products
60 products
| Image | Product | Reactivity | Target | Sensitivity | Detection Range | Price | Status | ACTION |
|---|---|---|---|---|---|---|---|---|
|
Target: Retatrutide |
Human | Retatrutide | 33.12 ng/mL | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Albiglutide |
Human | Albiglutide | 33.12 ng/mL | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Dulaglutide |
Human | Dulaglutide | 33.12 ng/mL | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Liraglutide |
Human | Liraglutide | 33.12 ng/mL | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Semaglutide |
Human | Semaglutide | — | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Orforglipron |
Human | Orforglipron | 33.12 ng/mL | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Tirzepatide |
Human | Tirzepatide | — | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Infliximab |
Human | Infliximab | 0.156 μg/ml | 0.31-5 μg/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Trastuzumab |
Human | Trastuzumab | 70.12 ng/mL | 78.13 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Adalimumab |
Human | Adalimumab | 0.156 μg/ml | 0.31-5 μg/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Bevacizumab |
Human | Bevacizumab | 98.1 ng/mL | 312.5 - 20,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Secukinumab |
Human | Secukinumab | 715.94 ng/mL. | 937.5 - 15,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Cetuximab |
Human | Cetuximab | — | 15.625-1,000 ng/ml |
$2,298.00
Regular price
$2,298.00
|
In Stock at Manufacturer | |
|
Target: Adalimumab |
Human | Adalimumab | — | 15.625-1,000 ng/ml |
$2,298.00
Regular price
$2,298.00
|
In Stock at Manufacturer | |
|
Target: Ustekinumab |
Human | Ustekinumab | — | 15.625-1,000 ng/ml |
$2,298.00
Regular price
$2,298.00
|
In Stock at Manufacturer | |
|
Target: Secukinumab |
Human | Secukinumab | — | 15.625-1,000 ng/ml |
$2,298.00
Regular price
$2,298.00
|
In Stock at Manufacturer | |
|
Target: Etanercept |
Human | Etanercept | — | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Etanercept |
Human | Etanercept | — | 15.625-1,000 ng/ml |
$2,298.00
Regular price
$2,298.00
|
In Stock at Manufacturer | |
|
Target: Bevacizumab |
Human | Bevacizumab | — | 15.625-1,000 ng/ml |
$2,298.00
Regular price
$2,298.00
|
In Stock at Manufacturer | |
|
Target: Ustekinumab |
Human | Ustekinumab | — | 31.25 - 2,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Etanercept |
Human | Etanercept | — | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Cetuximab |
Human | Cetuximab | — | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Rituximab |
Human | Rituximab | — | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Trastuzumab |
Human | Trastuzumab | — | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Adalimumab |
Human | Adalimumab | 83.1 ng/mL | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Bevacizumab |
Human | Bevacizumab | — | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Infliximab |
Human | Infliximab | — | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Cetuximab |
Human | Cetuximab | — | 78.125 - 5,000 ng/mL |
$1,226.00
Regular price
$1,226.00
|
In Stock at Manufacturer | |
|
Target: Ustekinumab |
Human | Ustekinumab | — | 156.25 - 10,000 ng/mL |
$1,498.00
Regular price
$1,498.00
|
In Stock at Manufacturer | |
|
Target: Trastuzumab Emtansine |
Universal | Trastuzumab Emtansine | 9.375ng/ml | 15.625-1000ng/ml |
$520.00
Regular price
$520.00
|
In Stock at Manufacturer | |
|
Target: Anti-T-DXd |
Human | Anti-T-DXd | 0.94ng/ml | 1.56-100ng/ml |
$520.00
Regular price
$520.00
|
In Stock at Manufacturer | |
|
Target: Anti-Ustekinumab antibody |
Human | Anti-Ustekinumab antibody | 0.938ng/ml | 1.563-100ng/ml |
$520.00
Regular price
$520.00
|
In Stock at Manufacturer | |
|
Target: Ustekinumab |
Human | Ustekinumab | 0.938ng/ml | 1.563-100ng/ml |
$520.00
Regular price
$520.00
|
In Stock at Manufacturer | |
|
Target: Anti-Rituximab antibody |
Human | Anti-Rituximab antibody | 0.469ng/ml | 0.781-50ng/ml |
$520.00
Regular price
$520.00
|
In Stock at Manufacturer | |
|
Target: Anti-trastuzumab antibody |
Human | Anti-trastuzumab antibody | 6ng/ml | 10-640ng/ml |
$520.00
Regular price
$520.00
|
In Stock at Manufacturer | |
|
Target: Anti-trastuzumab antibody |
Human | Anti-trastuzumab antibody | 0.469ng/ml | 0.781-50ng/ml |
$520.00
Regular price
$520.00
|
In Stock at Manufacturer |